6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one
C32H20N2O5 — CID 163681251
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one
6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one (PubChem CID 163681251) has the molecular formula C32H20N2O5 and a molecular weight of 512.52 g/mol. Its IUPAC name is 6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one.
Molecular Properties
| Compound Name | 6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one |
|---|---|
| PubChem CID | 163681251 |
| Molecular Formula | C32H20N2O5 |
| Molecular Weight | 512.52 g/mol |
| Exact Mass | 512.14 |
| IUPAC Name | 6-(benzo[f][1,3]benzoxazol-2-ylamino)-3'-hydroxy-6'-methylspiro[2-benzofuran-3,9'-xanthene]-1-one |
| SMILES | Cc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2cc(Nc3nc4cc5ccccc5cc4o3)ccc21 |
| InChI | InChI=1S/C32H20N2O5/c1-17-6-9-24-27(12-17)37-28-16-21(35)8-11-25(28)32(24)23-10-7-20(15-22(23)30(36)39-32)33-31-34-26-13-18-4-2-3-5-19(18)14-29(26)38-31/h2-16,35H,1H3,(H,33,34) |
| InChIKey | JLABHUJWQJSVBK-UHFFFAOYSA-N |
| XLogP | 7.31 |
| TPSA | 93.82 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 39 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 512.52 |
| LogP ≤ 5 | 7.31 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 163681251 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.